N-[(2S,3S,4R)-1-(alpha-D-Galactopyranosyloxy)-3,4-dihydroxy-2-octadecanyl]hexacosanamide

Basic Information

View in Editor

CAS Number

158021-47-7

Molecular Formula

C50H99NO9

Molecular Weight

858.34 g/mol

Chemical Classification

Basic Chemical Raw Materials Organic Chemicals Carboxylic Acids

Basic Chemical Raw Materials Organic Chemicals Ethers

Basic Chemical Raw Materials Organic Chemicals Heterocyclic Compounds

Pharmaceutical Chemicals Pharmaceutical Intermediates Heterocyclic Intermediates

Fine Chemicals Surfactants Anionic Surfactants

Polymers and Plastics Thermoplastics Polyolefins

Laboratory Chemicals Research Chemicals Biochemical Reagents

Basic Physical Properties

Melting Point

190°C

Boiling Point

939.8°Cat760mmHg

Flash Point

522.2°C

Solubility

Insuluble (1.6E-7 g/L) (25 ºC),

Refractive Index

1.512

SMILES

View in Editor

CCCCCCCCCCCCCCCCCCCCCCCCCC(=O)NC(COC1C(C(C(C(O1)CO)O)O)O)C(C(CCCCCCCCCCCCCC)O)O

InChI

InChI=1S/C50H99NO9/c1-3-5-7-9-11-13-15-17-18-19-20-21-22-23-24-25-26-27-29-31-33-35-37-39-45(54)51-42(41-59-50-49(58)48(57)47(56)44(40-52)60-50)46(55)43(53)38-36-34-32-30-28-16-14-12-10-8-6-4-2/h42-44,46-50,52-53,55-58H,3-41H2,1-2H3,(H,51,54)/t42-,43+,44+,46-,47-,48-,49+,50-/m0/s1

InChIKey

VQFKFAKEUMHBLV-BYSUZVQFSA-N

LogP

10.482999999999993

Topological Polar Surface Area

168.94 Å²

Hydrogen Bond Donor/Acceptor

7 / 10

Complexity

928

Safety Information

View Safety Information

Stability

Hygroscopic

Synonyms & References

English

(2S,3S,4R)-1-O-(alpha-D-Galactosyl)-N-hexacosanoyl-2-amino-1,3,4-octadecanetriol, >=95% (TLC)
1-O-(alpha-D-galactosyl)-N-hexacosanoylphytosphingosine
Hexacosanamide, N-[1-[(alpha-D-galactopyranosyloxy)methyl]-2,3-dihydroxyheptadecyl]-, [1S-(1R*,2R*,3S*)]-
alpha-Galactosylceramide(a-Gal-Cer) (synthetic)
N-((2S,3S,4R)-3,4-dihydroxy-1-(3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yloxy)octadecan-2-yl)hexaicosanamide
(2S,3S,4R)-1-O-(alpha-D-galactosyl)-N-hexacosanoyl-2-amino-1,3,4-octadecanetriol
158021-47-7
CCRIS 8968
CHEMBL384200
RGI-7000
AGL-582
Hexacosanamide, N-(1-((alpha-D-galactopyranosyloxy)methyl)-2,3-dihdyroxyheptadecyl)-, (1S-(1R*,2R*,3S*))-
HEXACOSANAMIDE, N-((1S,2S,3R)-1-((.ALPHA.-D-GALACTOPYRANOSYLOXY)METHYL)-2,3-DIHYDROXYHEPTADECYL)-
Hexacosanamide, N-[(1S,2S,3R)-1-[(alpha-D-galactopyranosyloxy)methyl]-2,3-dihydroxyheptadecyl]- (9CI)
RGI-2001
EX-A5755
N-{(1S,2S,3R)-1-[(alpha-D-galactopyranosyloxy)methyl]-2,3-dihydroxyheptadecyl}hexacosanamide
GLXC-26234
NS00073040
A-Galactosylceramide
SCHEMBL512949
Galalpha-Cer(t18:0/26:0)
UNII-WX671898JF
Epitope ID:130694
MFCD00939559
AC-31508
WX671898JF
Krn 7000
hexacosanamide, N-[(1S,2S,3R)-1-[(alpha-D-galactopyranosyloxy)methyl]-2,3-dihydroxyheptadecyl]-
CHEMID158021477

MDL Number

MFCD00939559

FAQ

What regulatory guidelines apply to N-[(2S,3S,4R)-1-(alpha-D-Galactopyranosyloxy)-3,4-dihydroxy-2-octadecanyl]hexacosanamide (CAS: 158021-47-7)?

N-[(2S,3S,4R)-1-(alpha-D-Galactopyranosyloxy)-3,4-dihydroxy-2-octadecanyl]hexacosanamide (CAS: 158021-47-7) falls under various regulatory guidelines such as GHS classification for hazardous substances, REACH regulations for European manufacturers and importers, and FDA/EPA requirements for medical and environmental safety. Compliance with these guidelines is essential for handling, storage, and disposal of the compound.

Are there alternatives to N-[(2S,3S,4R)-1-(alpha-D-Galactopyranosyloxy)-3,4-dihydroxy-2-octadecanyl]hexacosanamide (CAS: 158021-47-7) in synthesis?

In synthesis, alternatives to N-[(2S,3S,4R)-1-(alpha-D-Galactopyranosyloxy)-3,4-dihydroxy-2-octadecanyl]hexacosanamide (CAS: 158021-47-7) include other galactosides and similar amides. Common alternatives include D-galactosyl derivatives and various esters. These can serve as substitutes depending on the specific application and reactivity requirements.

What is the market or research trend for N-[(2S,3S,4R)-1-(alpha-D-Galactopyranosyloxy)-3,4-dihydroxy-2-octadecanyl]hexacosanamide (CAS: 158021-47-7)?

N-[(2S,3S,4R)-1-(alpha-D-Galactopyranosyloxy)-3,4-dihydroxy-2-octadecanyl]hexacosanamide (CAS: 158021-47-7) is increasingly being explored in research for its potential in pharmaceuticals and biochemistry. Market trends show growing interest in natural product derivatives and their applications in medicine and biotechnology, driven by the need for novel therapeutic agents and biomolecules.

How should waste containing N-[(2S,3S,4R)-1-(alpha-D-Galactopyranosyloxy)-3,4-dihydroxy-2-octadecanyl]hexacosanamide (CAS: 158021-47-7) be handled?

Waste containing N-[(2S,3S,4R)-1-(alpha-D-Galactopyranosyloxy)-3,4-dihydroxy-2-octadecanyl]hexacosanamide (CAS: 158021-47-7) should be collected in appropriate containers and disposed of according to local regulations. Incineration or professional waste disposal services are recommended for safe removal. Environmental protection measures include minimizing contamination during handling and adhering to best practices to prevent release into the environment.